Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource]
author
Kovacovicova, Kristina
Školnaja, Marianna
Heinmaa, Mihkel
Mistrik, Martin
Pata, Pille
Pata, Illar
statement of authorship
Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek and Manlio Vinciguerra
source
Frontiers in oncology
journal volume number month
vol. 8
year of publication
2018
pages
art. 459, 7 p. : ill
url
https://doi.org/10.3389/fonc.2018.00459
subject term
maksahaigused
ravimiarendus
keyword
NAFLD (non-alcoholic fatty liver disease)
HCC (hepatocellular carcinoma)
senolytic agents
quercertin
dasatinib
ISSN
2234-943X
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
Journal metrics at Scopus
Article at Scopus
WOS
Journal metrics at WOS
Article at WOS
category (general)
Medicine
en
Biochemistry, genetics and molecular biology
en
Meditsiin
et
Biokeemia, geneetika ja molekulaarbioloogia
et
category (sub)
Medicine. Oncology
en
Biochemistry, genetics and molecular biology. Cancer research
en
Meditsiin. Onkoloogia
et
Biokeemia, geneetika ja molekulaarbioloogia. Vähiuuringud
et
kvartiil
Q1
TTÜ department
keemia ja biotehnoloogia instituut
language
inglise
Uurimisrühm
Laboratory of biofunctional materials
Microfluidics group